Non-small cell lung cancer (NSCLC) Research Samples
96 Results
1 - 96 of 96 total samples.
Advanced Data View:
1 - 96 of 96 total samples.
Buy | Product ID | Sample | Origin | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test 1 Result | Test 1 Detail | Test 2 | Test 2 Result | Test 3 | Test 3 Result | Product Details | Price | Buy | Histological conclusion | Treatment status | TNM: | Stage | Grade | CT / MRI results | HIV-I/II, Hepatitis B, Hepatitis C Test Results |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BF19871322 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 60 Y | F | White | <-70C | 16-Oct-25 | Diagnosis | Lung Cancer | 10-Oct-2025 | Height | 155 cm | Weight | 62 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T2aN0M1 | IV | G2 | Formation of the upper lobe of the right lung, lymph nodes unchanged, metastases to the ribs | Negative | |||
| BF19871322-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 60 Y | F | White | <-70C | 16-Oct-25 | Diagnosis | Lung Cancer | 10-Oct-2025 | Height | 155 cm | Weight | 62 kg | $450.00 | Adenocarcinoma | Treatment-naive | T2aN0M1 | IV | G2 | Formation of the upper lobe of the right lung, lymph nodes unchanged, metastases to the ribs | Negative | |||
| BF19871323 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 57 Y | F | White | <-70C | 31-Oct-25 | Diagnosis | Lung Cancer | 15-Oct-2025 | Height | 162 cm | Weight | 74 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T3N2M1 | IV | G2 | Formation of the middle lobe of the right lung with metastases to the mediastinal lymph nodes and with metastases to the ribs | Negative | |||
| BF19871323-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 16.00 | $450.00 | 57 Y | F | White | <-70C | 31-Oct-25 | Diagnosis | Lung Cancer | 15-Oct-2025 | Height | 162 cm | Weight | 74 kg | $450.00 | Adenocarcinoma | Treatment-naive | T3N2M1 | IV | G2 | Formation of the middle lobe of the right lung with metastases to the mediastinal lymph nodes and with metastases to the ribs | Negative | |||
| BF19871324 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 64 Y | M | White | <-70C | 16-Oct-25 | Diagnosis | Lung Cancer | 7-Oct-2025 | Height | 178 cm | Weight | 82 kg | $1,800.00 | Large cell carcinoma | Treatment-naive | T2N2M1 | IV | G2 | Formation of the lower lobe of the right lung with metastases to regional lymph nodes and distant metastases to the pleura | Negative | |||
| BF19871324-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 64 Y | M | White | <-70C | 16-Oct-25 | Diagnosis | Lung Cancer | 7-Oct-2025 | Height | 178 cm | Weight | 82 kg | $450.00 | Large cell carcinoma | Treatment-naive | T2N2M1 | IV | G2 | Formation of the lower lobe of the right lung with metastases to regional lymph nodes and distant metastases to the pleura | Negative | |||
| BF19871325 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 78 Y | F | White | <-70C | 14-Oct-25 | Diagnosis | Lung Cancer | 8-Oct-2025 | Height | 161 cm | Weight | 71 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T2aN1M1 | IV | G2 | Formation of the lower lobe of the right lung with metastases to regional lymph nodes and distant metastases to the liver | Negative | |||
| BF19871325-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 13.00 | $450.00 | 78 Y | F | White | <-70C | 14-Oct-25 | Diagnosis | Lung Cancer | 8-Oct-2025 | Height | 161 cm | Weight | 71 kg | $450.00 | Adenocarcinoma | Treatment-naive | T2aN1M1 | IV | G2 | Formation of the lower lobe of the right lung with metastases to regional lymph nodes and distant metastases to the liver | Negative | |||
| BF19871326 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 74 Y | M | White | <-70C | 28-Oct-25 | Diagnosis | Lung Cancer | 24-Oct-2025 | Height | 172 cm | Weight | 84 kg | $1,800.00 | Squamous cell carcinoma | Treatment-naive | T2aN2M1 | IV | G3 | Formation of the lower lobe of the left lung with metastases to regional lymph nodes and to the liver | Negative | |||
| BF19871326-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 74 Y | M | White | <-70C | 28-Oct-25 | Diagnosis | Lung Cancer | 24-Oct-2025 | Height | 172 cm | Weight | 84 kg | $450.00 | Squamous cell carcinoma | Treatment-naive | T2aN2M1 | IV | G3 | Formation of the lower lobe of the left lung with metastases to regional lymph nodes and to the liver | Negative | |||
| BF19871327 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 65 Y | M | White | <-70C | 21-Oct-25 | Diagnosis | Lung Cancer | 16-Oct-2025 | Height | 173 cm | Weight | 81 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T4N1M1 | IV | G1 | Formation of the upper lobe of the right lung with metastases to regional lymph nodes and pleura | Negative | |||
| BF19871327-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 65 Y | M | White | <-70C | 21-Oct-25 | Diagnosis | Lung Cancer | 16-Oct-2025 | Height | 173 cm | Weight | 81 kg | $450.00 | Adenocarcinoma | Treatment-naive | T4N1M1 | IV | G1 | Formation of the upper lobe of the right lung with metastases to regional lymph nodes and pleura | Negative | |||
| BF19871328 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 68 Y | M | White | <-70C | 17-Oct-25 | Diagnosis | Lung Cancer | 13-Oct-2025 | Height | 171 cm | Weight | 94 kg | $1,800.00 | Squamous cell carcinoma | Treatment-naive | T2aN1M1 | IV | G2 | Formation of the middle lobe of the right lung with metastases to regional lymph nodes and ribs | Negative | |||
| BF19871328-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 13.00 | $450.00 | 68 Y | M | White | <-70C | 17-Oct-25 | Diagnosis | Lung Cancer | 13-Oct-2025 | Height | 171 cm | Weight | 94 kg | $450.00 | Squamous cell carcinoma | Treatment-naive | T2aN1M1 | IV | G2 | Formation of the middle lobe of the right lung with metastases to regional lymph nodes and ribs | Negative | |||
| BF19871329 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 74 Y | M | White | <-70C | 15-Oct-25 | Diagnosis | Lung Cancer | 9-Oct-2025 | Height | 174 cm | Weight | 83 kg | $1,800.00 | Squamous cell carcinoma | Treatment-naive | T1cN0M1 | IV | G2 | Formation of the lower lobe of the right lung with metastases to the liver, lymph nodes unchanged | Negative | |||
| BF19871329-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 13.00 | $450.00 | 74 Y | M | White | <-70C | 15-Oct-25 | Diagnosis | Lung Cancer | 9-Oct-2025 | Height | 174 cm | Weight | 83 kg | $450.00 | Squamous cell carcinoma | Treatment-naive | T1cN0M1 | IV | G2 | Formation of the lower lobe of the right lung with metastases to the liver, lymph nodes unchanged | Negative | |||
| BF19871330 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 61 Y | F | White | <-70C | 23-Oct-25 | Diagnosis | Lung Cancer | 10-Oct-2025 | Height | 174 cm | Weight | 83 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T3N1M1 | IV | G2 | Formation of the right lower lobe lung with metastases to the mediastinal lymph nodes and pleura | Negative | |||
| BF19871330-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 61 Y | F | White | <-70C | 23-Oct-25 | Diagnosis | Lung Cancer | 10-Oct-2025 | Height | 174 cm | Weight | 83 kg | $450.00 | Adenocarcinoma | Treatment-naive | T3N1M1 | IV | G2 | Formation of the right lower lobe lung with metastases to the mediastinal lymph nodes and pleura | Negative | |||
| BF19871414 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 67 Y | F | White | <-70C | 21-Nov-25 | Diagnosis | Lung Cancer | 17-Nov-2025 | Height | 171 cm | Weight | 74 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T4N1M1 | IV | G2 | Formation of the lower lobe of the left lung with metastases to regional lymph nodes and pleura | Negative | |||
| BF19871414-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 13.00 | $450.00 | 67 Y | F | White | <-70C | 21-Nov-25 | Diagnosis | Lung Cancer | 17-Nov-2025 | Height | 171 cm | Weight | 74 kg | $450.00 | Adenocarcinoma | Treatment-naive | T4N1M1 | IV | G2 | Formation of the lower lobe of the left lung with metastases to regional lymph nodes and pleura | Negative | |||
| BF19871415 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 68 Y | M | White | <-70C | 17-Nov-25 | Diagnosis | Lung Cancer | 30-Oct-2025 | Height | 181 cm | Weight | 79 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T2bN1M1 | IV | G3 | Formation of the upper lobe of the right lung with metastases to the mediastinal lymph nodes and pleura | Negative | |||
| BF19871415-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 13.00 | $450.00 | 68 Y | M | White | <-70C | 17-Nov-25 | Diagnosis | Lung Cancer | 30-Oct-2025 | Height | 181 cm | Weight | 79 kg | $450.00 | Adenocarcinoma | Treatment-naive | T2bN1M1 | IV | G3 | Formation of the upper lobe of the right lung with metastases to the mediastinal lymph nodes and pleura | Negative | |||
| BF19871416 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 63 Y | F | White | <-70C | 23-Oct-25 | Diagnosis | Lung Cancer | 18-Oct-2025 | Height | 164 cm | Weight | 72 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T2bN2M1 | IV | G2 | Formation of the lower lobe of the left lung with metastases to regional lymph nodes and pleura | Negative | |||
| BF19871416-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 63 Y | F | White | <-70C | 23-Oct-25 | Diagnosis | Lung Cancer | 18-Oct-2025 | Height | 164 cm | Weight | 72 kg | $450.00 | Adenocarcinoma | Treatment-naive | T2bN2M1 | IV | G2 | Formation of the lower lobe of the left lung with metastases to regional lymph nodes and pleura | Negative | |||
| BF19871417 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 68 Y | M | White | <-70C | 13-Nov-25 | Diagnosis | Lung Cancer | 1-Nov-2025 | Height | 172 cm | Weight | 56 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T3N1M1 | IV | G2 | Formation of the upper lobe of the right lung with metastases to the mediastinal lymph nodes and pleura | Negative | |||
| BF19871417-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 68 Y | M | White | <-70C | 13-Nov-25 | Diagnosis | Lung Cancer | 1-Nov-2025 | Height | 172 cm | Weight | 56 kg | $450.00 | Adenocarcinoma | Treatment-naive | T3N1M1 | IV | G2 | Formation of the upper lobe of the right lung with metastases to the mediastinal lymph nodes and pleura | Negative | |||
| BF19871418 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 60 Y | F | White | <-70C | 03-Nov-25 | Diagnosis | Lung Cancer | 17-Oct-2025 | Height | 168 cm | Weight | 87 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T2aN1M1 | IV | G2 | Formation of the upper lobe of the right lung with metastases to the mediastinal lymph nodes and pleura | Negative | |||
| BF19871418-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 16.00 | $450.00 | 60 Y | F | White | <-70C | 03-Nov-25 | Diagnosis | Lung Cancer | 17-Oct-2025 | Height | 168 cm | Weight | 87 kg | $450.00 | Adenocarcinoma | Treatment-naive | T2aN1M1 | IV | G2 | Formation of the upper lobe of the right lung with metastases to the mediastinal lymph nodes and pleura | Negative | |||
| BF19871455 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 63 Y | F | White | <-70C | 26-Nov-25 | Diagnosis | Lung cancer | 12-Nov-25 | Height | 171 cm | Weight | 70 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T2aN2M1 | IV | G3 | Formation of the lower lobe of the left lung with metastases to regional lymph nodes and pleura | Negative | |||
| BF19871455-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 63 Y | F | White | <-70C | 26-Nov-25 | Diagnosis | Lung cancer | 12-Nov-25 | Height | 171 cm | Weight | 70 kg | $450.00 | Adenocarcinoma | Treatment-naive | T2aN2M1 | IV | G3 | Formation of the lower lobe of the left lung with metastases to regional lymph nodes and pleura | Negative | |||
| BF19871456 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 76 Y | F | White | <-70C | 04-Dec-25 | Diagnosis | Lung cancer | 20-Nov-25 | Height | 164 cm | Weight | 70 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T2aN0M1 | IV | G2 | Formation of the upper lobe of the right lung with metastases to the lower lobe of the right lung | Negative | |||
| BF19871456-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 76 Y | F | White | <-70C | 04-Dec-25 | Diagnosis | Lung cancer | 20-Nov-25 | Height | 164 cm | Weight | 70 kg | $450.00 | Adenocarcinoma | Treatment-naive | T2aN0M1 | IV | G2 | Formation of the upper lobe of the right lung with metastases to the lower lobe of the right lung | Negative | |||
| BF19871457 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 71 Y | F | White | <-70C | 15-Dec-25 | Diagnosis | Lung cancer | 1-Dec-25 | Height | 156 cm | Weight | 68 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T4N2M1 | IV | G3 | Formation of the middle lobe of the left lung with metastases to the pleura and pericardium | Negative | |||
| BF19871457-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 71 Y | F | White | <-70C | 15-Dec-25 | Diagnosis | Lung cancer | 1-Dec-25 | Height | 156 cm | Weight | 68 kg | $450.00 | Adenocarcinoma | Treatment-naive | T4N2M1 | IV | G3 | Formation of the middle lobe of the left lung with metastases to the pleura and pericardium | Negative | |||
| BF19871458 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 64 Y | M | White | <-70C | 10-Dec-25 | Diagnosis | Lung cancer | 20-Nov-25 | Height | 174 cm | Weight | 81 kg | $1,800.00 | Squamous cell carcinoma | Treatment-naive | T3N1M1 | IV | G3 | Formation of the upper lobe of the left lung with metastases to the regional lymph nodes and liver | Negative | |||
| BF19871458-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 15.00 | $450.00 | 64 Y | M | White | <-70C | 10-Dec-25 | Diagnosis | Lung cancer | 20-Nov-25 | Height | 174 cm | Weight | 81 kg | $450.00 | Squamous cell carcinoma | Treatment-naive | T3N1M1 | IV | G3 | Formation of the upper lobe of the left lung with metastases to the regional lymph nodes and liver | Negative | |||
| BF19871459 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 51 Y | F | White | <-70C | 04-Dec-25 | Diagnosis | Lung cancer | 19-Nov-25 | Height | 167 cm | Weight | 71 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T4N2M1 | IV | G2 | Formation of the lower lobe of the right lung with metastases to the regional lymph nodes and pleura | Negative | |||
| BF19871459-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 51 Y | F | White | <-70C | 04-Dec-25 | Diagnosis | Lung cancer | 19-Nov-25 | Height | 167 cm | Weight | 71 kg | $450.00 | Adenocarcinoma | Treatment-naive | T4N2M1 | IV | G2 | Formation of the lower lobe of the right lung with metastases to the regional lymph nodes and pleura | Negative | |||
| BF19871460 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 69 Y | M | White | <-70C | 11-Dec-25 | Diagnosis | Lung cancer | 28-Nov-25 | Height | 165 cm | Weight | 60 kg | $1,800.00 | Squamous cell carcinoma | Treatment-naive | T2N2M1 | IV | G3 | Formation of the upper lobe of the left lung with metastases to the regional lymph nodes and parietal pleura | Negative | |||
| BF19871460-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 69 Y | M | White | <-70C | 11-Dec-25 | Diagnosis | Lung cancer | 28-Nov-25 | Height | 165 cm | Weight | 60 kg | $450.00 | Squamous cell carcinoma | Treatment-naive | T2N2M1 | IV | G3 | Formation of the upper lobe of the left lung with metastases to the regional lymph nodes and parietal pleura | Negative | |||
| BF19871461 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 59 Y | M | White | <-70C | 05-Dec-25 | Diagnosis | Lung cancer | 24-Nov-25 | Height | 175 cm | Weight | 85 kg | $1,800.00 | Squamous cell carcinoma | Treatment-naive | T2aN2M1 | IV | G2 | Formation of the upper lobe of the right lung with metastases to the regional lymph nodes and liver | Negative | |||
| BF19871461-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 59 Y | M | White | <-70C | 05-Dec-25 | Diagnosis | Lung cancer | 24-Nov-25 | Height | 175 cm | Weight | 85 kg | $450.00 | Squamous cell carcinoma | Treatment-naive | T2aN2M1 | IV | G2 | Formation of the upper lobe of the right lung with metastases to the regional lymph nodes and liver | Negative | |||
| BF19871462 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 67 Y | M | White | <-70C | 15-Dec-25 | Diagnosis | Lung cancer | 1-Dec-25 | Height | 170 cm | Weight | 72 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T4N2M1 | IV | G3 | Formation of the lower lobe of the left lung with metastases to the regional lymph nodes and pleura | Negative | |||
| BF19871462-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 67 Y | M | White | <-70C | 15-Dec-25 | Diagnosis | Lung cancer | 1-Dec-25 | Height | 170 cm | Weight | 72 kg | $450.00 | Adenocarcinoma | Treatment-naive | T4N2M1 | IV | G3 | Formation of the lower lobe of the left lung with metastases to the regional lymph nodes and pleura | Negative | |||
| BF19871463 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 72 Y | M | White | <-70C | 15-Dec-25 | Diagnosis | Lung cancer | 2-Dec-25 | Height | 173 cm | Weight | 70 kg | $1,800.00 | Squamous cell carcinoma | Treatment-naive | T4N1M1 | IV | G2 | Formation of the upper lobe of the right lung with metastases to the regional lymph nodes and pleura | Negative | |||
| BF19871463-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 72 Y | M | White | <-70C | 15-Dec-25 | Diagnosis | Lung cancer | 2-Dec-25 | Height | 173 cm | Weight | 70 kg | $450.00 | Squamous cell carcinoma | Treatment-naive | T4N1M1 | IV | G2 | Formation of the upper lobe of the right lung with metastases to the regional lymph nodes and pleura | Negative | |||
| BF19871464 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 68 Y | M | White | <-70C | 12-Dec-25 | Diagnosis | Lung cancer | 29-Nov-25 | Height | 168 cm | Weight | 62 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T3N2M1 | IV | G3 | Formation of the lower lobe of the left lung with metastases to regional lymph nodes and pleura | Negative | |||
| BF19871464-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 68 Y | M | White | <-70C | 12-Dec-25 | Diagnosis | Lung cancer | 29-Nov-25 | Height | 168 cm | Weight | 62 kg | $450.00 | Adenocarcinoma | Treatment-naive | T3N2M1 | IV | G3 | Formation of the lower lobe of the left lung with metastases to regional lymph nodes and pleura | Negative | |||
| BF19871465 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 58 Y | M | White | <-70C | 11-Dec-25 | Diagnosis | Lung cancer | 27-Nov-25 | Height | 174 cm | Weight | 75 kg | $1,800.00 | Squamous cell carcinoma | Treatment-naive | T2bN0M1 | IV | G3 | Formation of the lower lobe of the right lung with metastases to the pleura | Negative | |||
| BF19871465-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 58 Y | M | White | <-70C | 11-Dec-25 | Diagnosis | Lung cancer | 27-Nov-25 | Height | 174 cm | Weight | 75 kg | $450.00 | Squamous cell carcinoma | Treatment-naive | T2bN0M1 | IV | G3 | Formation of the lower lobe of the right lung with metastases to the pleura | Negative | |||
| BF19871466 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 59 Y | F | White | <-70C | 31-Dec-25 | Diagnosis | Lung cancer | 17-Dec-25 | Height | 171 cm | Weight | 85 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T1cN2M1 | IV | G2 | Formation of the lower lobe of the right lung with metastases to the regional lymph nodes and pleura | Negative | |||
| BF19871466-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 59 Y | F | White | <-70C | 31-Dec-25 | Diagnosis | Lung cancer | 17-Dec-25 | Height | 171 cm | Weight | 85 kg | $450.00 | Adenocarcinoma | Treatment-naive | T1cN2M1 | IV | G2 | Formation of the lower lobe of the right lung with metastases to the regional lymph nodes and pleura | Negative | |||
| BF19871467 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 54 Y | F | White | <-70C | 16-Jan-26 | Diagnosis | Lung cancer | 2-Jan-26 | Height | 171 cm | Weight | 65 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T2N1M1 | IV | G3 | Formation of the lower lobe of the left lung with metastases to the regional lymph nodes and right lung | Negative | |||
| BF19871467-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 54 Y | F | White | <-70C | 16-Jan-26 | Diagnosis | Lung cancer | 2-Jan-26 | Height | 171 cm | Weight | 65 kg | $450.00 | Adenocarcinoma | Treatment-naive | T2N1M1 | IV | G3 | Formation of the lower lobe of the left lung with metastases to the regional lymph nodes and right lung | Negative | |||
| BF19871468 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 66 Y | M | White | <-70C | 14-Jan-26 | Diagnosis | Lung cancer | 31-Dec-25 | Height | 170 cm | Weight | 80 kg | $1,800.00 | Squamous cell carcinoma | Treatment-naive | T2N1M1 | IV | G2 | Formation of the lower lobe of the left lung with metastases to the regional lymph nodes and liver | Negative | |||
| BF19871468-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 66 Y | M | White | <-70C | 14-Jan-26 | Diagnosis | Lung cancer | 31-Dec-25 | Height | 170 cm | Weight | 80 kg | $450.00 | Squamous cell carcinoma | Treatment-naive | T2N1M1 | IV | G2 | Formation of the lower lobe of the left lung with metastases to the regional lymph nodes and liver | Negative | |||
| BF19871469 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 75 Y | F | White | <-70C | 12-Jan-26 | Diagnosis | Lung cancer | 12-Dec-25 | Height | 160 cm | Weight | 65 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T4N1M1 | IV | G2 | Formation of the upper lobe of the right lung lung with metastases to the regional lymph nodes and left lung | Negative | |||
| BF19871469-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 75 Y | F | White | <-70C | 12-Jan-26 | Diagnosis | Lung cancer | 12-Dec-25 | Height | 160 cm | Weight | 65 kg | $450.00 | Adenocarcinoma | Treatment-naive | T4N1M1 | IV | G2 | Formation of the upper lobe of the right lung lung with metastases to the regional lymph nodes and left lung | Negative | |||
| BF19871470 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 67 Y | M | White | <-70C | 05-Jan-26 | Diagnosis | Lung cancer | 29-Dec-25 | Height | 174 cm | Weight | 70 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T2N2M1 | IV | G3 | Formation of the upper lobe of the right lung lung with metastases to the regional lymph nodes and pleura | Negative | |||
| BF19871470-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 67 Y | M | White | <-70C | 05-Jan-26 | Diagnosis | Lung cancer | 29-Dec-25 | Height | 174 cm | Weight | 70 kg | $450.00 | Adenocarcinoma | Treatment-naive | T2N2M1 | IV | G3 | Formation of the upper lobe of the right lung lung with metastases to the regional lymph nodes and pleura | Negative | |||
| BF19871471 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 62 Y | F | White | <-70C | 02-Jan-26 | Diagnosis | Lung cancer | 26-Dec-25 | Height | 173 cm | Weight | 70 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T3N1M1 | IV | G3 | Formation of the upper lobe of the right lung with metastases to the regional lymph nodes and parietal pleura | Negative | |||
| BF19871471-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 62 Y | F | White | <-70C | 02-Jan-26 | Diagnosis | Lung cancer | 26-Dec-25 | Height | 173 cm | Weight | 70 kg | $450.00 | Adenocarcinoma | Treatment-naive | T3N1M1 | IV | G3 | Formation of the upper lobe of the right lung with metastases to the regional lymph nodes and parietal pleura | Negative | |||
| BF19871472 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 75 Y | M | White | <-70C | 23-Dec-25 | Diagnosis | Lung cancer | 9-Dec-25 | Height | 180 cm | Weight | 80 kg | $1,800.00 | Squamous cell carcinoma | Treatment-naive | T3N1M1 | IV | G2 | Formation of the lower lobe of the left lung with metastases to the regional lymph nodes and pleura | Negative | |||
| BF19871472-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 75 Y | M | White | <-70C | 23-Dec-25 | Diagnosis | Lung cancer | 9-Dec-25 | Height | 180 cm | Weight | 80 kg | $450.00 | Squamous cell carcinoma | Treatment-naive | T3N1M1 | IV | G2 | Formation of the lower lobe of the left lung with metastases to the regional lymph nodes and pleura | Negative | |||
| BF19871473 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 63 Y | M | White | <-70C | 19-Dec-25 | Diagnosis | Lung cancer | 8-Dec-25 | Height | 178 cm | Weight | 84 kg | $1,800.00 | Squamous cell carcinoma | Treatment-naive | T1cN1M1 | IV | G2 | Formation of the upper lobe of the left lung with metastases to the mediastinal lymph nodes and right lung | Negative | |||
| BF19871473-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 63 Y | M | White | <-70C | 19-Dec-25 | Diagnosis | Lung cancer | 8-Dec-25 | Height | 178 cm | Weight | 84 kg | $450.00 | Squamous cell carcinoma | Treatment-naive | T1cN1M1 | IV | G2 | Formation of the upper lobe of the left lung with metastases to the mediastinal lymph nodes and right lung | Negative | |||
| BF19871474 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 59 Y | F | White | <-70C | 20-Jan-26 | Diagnosis | Lung cancer | 30-Dec-25 | Height | 157 cm | Weight | 82 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T3N2M1 | IV | G3 | Formation of the lower lobe of the right lung with metastases to the regional lymph nodes and left lung | Negative | |||
| BF19871474-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 59 Y | F | White | <-70C | 20-Jan-26 | Diagnosis | Lung cancer | 30-Dec-25 | Height | 157 cm | Weight | 82 kg | $450.00 | Adenocarcinoma | Treatment-naive | T3N2M1 | IV | G3 | Formation of the lower lobe of the right lung with metastases to the regional lymph nodes and left lung | Negative | |||
| BF19871475 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 73 Y | M | White | <-70C | 07-Jan-26 | Diagnosis | Lung cancer | 15-Dec-25 | Height | 176 cm | Weight | 82 kg | $1,800.00 | Squamous cell carcinoma | Treatment-naive | T3N0M1 | IV | G3 | Formation of the upper lobe of the right lung with metastases to the pleura | Negative | |||
| BF19871475-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 73 Y | M | White | <-70C | 07-Jan-26 | Diagnosis | Lung cancer | 15-Dec-25 | Height | 176 cm | Weight | 82 kg | $450.00 | Squamous cell carcinoma | Treatment-naive | T3N0M1 | IV | G3 | Formation of the upper lobe of the right lung with metastases to the pleura | Negative | |||
| BF19871476 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 64 Y | M | White | <-70C | 06-Jan-26 | Diagnosis | Lung cancer | 22-Dec-25 | Height | 174 cm | Weight | 78 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T4N2M1 | IV | G2 | Formation of the upper lobe of the right lung with metastases to the regional lymph nodes and pleura | Negative | |||
| BF19871476-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 64 Y | M | White | <-70C | 06-Jan-26 | Diagnosis | Lung cancer | 22-Dec-25 | Height | 174 cm | Weight | 78 kg | $450.00 | Adenocarcinoma | Treatment-naive | T4N2M1 | IV | G2 | Formation of the upper lobe of the right lung with metastases to the regional lymph nodes and pleura | Negative | |||
| BF19871477 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 58 Y | F | White | <-70C | 27-Jan-26 | Diagnosis | Lung cancer | 13-Jan-26 | Height | 172 cm | Weight | 112 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T1bN1M1 | IV | G3 | Formation of the lower lobe of the left lung with metastases to the regional lymph nodes and right lung | Negative | |||
| BF19871477-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 58 Y | F | White | <-70C | 27-Jan-26 | Diagnosis | Lung cancer | 13-Jan-26 | Height | 172 cm | Weight | 112 kg | $450.00 | Adenocarcinoma | Treatment-naive | T1bN1M1 | IV | G3 | Formation of the lower lobe of the left lung with metastases to the regional lymph nodes and right lung | Negative | |||
| BF19871478 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 60 Y | F | White | <-70C | 04-Feb-26 | Diagnosis | Lung cancer | 14-Jan-26 | Height | 169 cm | Weight | 73 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T3N2M1 | IV | G3 | Formation of the middle lobe of the right lung with metastases to the regional lymph nodes and liver | Negative | |||
| BF19871478-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 60 Y | F | White | <-70C | 04-Feb-26 | Diagnosis | Lung cancer | 14-Jan-26 | Height | 169 cm | Weight | 73 kg | $450.00 | Adenocarcinoma | Treatment-naive | T3N2M1 | IV | G3 | Formation of the middle lobe of the right lung with metastases to the regional lymph nodes and liver | Negative | |||
| BF19871479 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 60 Y | M | White | <-70C | 04-Feb-26 | Diagnosis | Lung cancer | 13-Jan-26 | Height | 176 cm | Weight | 85 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T3N2M1 | IV | G3 | Formation of the upper lobe of the right lung with metastases to the regional lymph nodes and left lung | Negative | |||
| BF19871479-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 60 Y | M | White | <-70C | 04-Feb-26 | Diagnosis | Lung cancer | 13-Jan-26 | Height | 176 cm | Weight | 85 kg | $450.00 | Adenocarcinoma | Treatment-naive | T3N2M1 | IV | G3 | Formation of the upper lobe of the right lung with metastases to the regional lymph nodes and left lung | Negative | |||
| BF19871480 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 66 Y | F | White | <-70C | 29-Jan-26 | Diagnosis | Lung cancer | 16-Jan-26 | Height | 171 cm | Weight | 81 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T1сN1M1 | IV | G2 | Formation of the upper lobe of the left lung with metastases to the regional lymph nodes and pleura | Negative | |||
| BF19871480-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 66 Y | F | White | <-70C | 29-Jan-26 | Diagnosis | Lung cancer | 16-Jan-26 | Height | 171 cm | Weight | 81 kg | $450.00 | Adenocarcinoma | Treatment-naive | T1сN1M1 | IV | G2 | Formation of the upper lobe of the left lung with metastases to the regional lymph nodes and pleura | Negative | |||
| BF19871481 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 76 Y | M | White | <-70C | 03-Feb-26 | Diagnosis | Lung cancer | 19-Jan-26 | Height | 171 cm | Weight | 62 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T2N1M1 | IV | G3 | Formation of the upper lobe of the left lung with metastases to the regional lymph nodes and bones | Negative | |||
| BF19871481-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 76 Y | M | White | <-70C | 03-Feb-26 | Diagnosis | Lung cancer | 19-Jan-26 | Height | 171 cm | Weight | 62 kg | $450.00 | Adenocarcinoma | Treatment-naive | T2N1M1 | IV | G3 | Formation of the upper lobe of the left lung with metastases to the regional lymph nodes and bones | Negative | |||
| BF19871482 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 67 Y | F | White | <-70C | 05-Feb-26 | Diagnosis | Lung cancer | 22-Jan-26 | Height | 162 cm | Weight | 81 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T2N2M1 | IV | G3 | Formation of the lower lobe of the left lung with metastases to the regional lymph nodes and pleura | Negative | |||
| BF19871482-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 67 Y | F | White | <-70C | 05-Feb-26 | Diagnosis | Lung cancer | 22-Jan-26 | Height | 162 cm | Weight | 81 kg | $450.00 | Adenocarcinoma | Treatment-naive | T2N2M1 | IV | G3 | Formation of the lower lobe of the left lung with metastases to the regional lymph nodes and pleura | Negative | |||
| BF19871483 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 72 Y | M | White | <-70C | 05-Feb-26 | Diagnosis | Lung cancer | 19-Jan-26 | Height | 168 cm | Weight | 71 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T1bN2M1 | IV | G3 | Formation of the upper lobe of the left lung with metastases to the regional lymph nodes and right lung | Negative | |||
| BF19871483-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 72 Y | M | White | <-70C | 05-Feb-26 | Diagnosis | Lung cancer | 19-Jan-26 | Height | 168 cm | Weight | 71 kg | $450.00 | Adenocarcinoma | Treatment-naive | T1bN2M1 | IV | G3 | Formation of the upper lobe of the left lung with metastases to the regional lymph nodes and right lung | Negative | |||
| BF19871484 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 68 Y | M | White | <-70C | 09-Feb-26 | Diagnosis | Lung cancer | 26-Jan-26 | Height | 173 cm | Weight | 85 kg | $1,800.00 | Squamous cell carcinoma | Treatment-naive | T2aN1M1 | IV | G3 | Formation of the upper lobe of the right lung with metastases to the regional lymph and bones | Negative | |||
| BF19871484-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 68 Y | M | White | <-70C | 09-Feb-26 | Diagnosis | Lung cancer | 26-Jan-26 | Height | 173 cm | Weight | 85 kg | $450.00 | Squamous cell carcinoma | Treatment-naive | T2aN1M1 | IV | G3 | Formation of the upper lobe of the right lung with metastases to the regional lymph and bones | Negative | |||
| BF19871485 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 69 Y | M | White | <-70C | 09-Feb-26 | Diagnosis | Lung cancer | 27-Jan-26 | Height | 171 cm | Weight | 80 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T2aN2M1 | IV | G2 | Formation of the upper lobe of the right lung with metastases to the regional lymph nodes and pleura | Negative | |||
| BF19871485-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 69 Y | M | White | <-70C | 09-Feb-26 | Diagnosis | Lung cancer | 27-Jan-26 | Height | 171 cm | Weight | 80 kg | $450.00 | Adenocarcinoma | Treatment-naive | T2aN2M1 | IV | G2 | Formation of the upper lobe of the right lung with metastases to the regional lymph nodes and pleura | Negative | |||
| BF19871486 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 77 Y | F | White | <-70C | 03-Feb-26 | Diagnosis | Lung cancer | 20-Jan-26 | Height | 173 cm | Weight | 71 kg | $1,800.00 | Squamous cell carcinoma | Treatment-naive | T3N2M1 | IV | G3 | Formation of the lower lobe of the right lung with metastases to the regional lymph nodes and pleura | Negative | |||
| BF19871486-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 77 Y | F | White | <-70C | 03-Feb-26 | Diagnosis | Lung cancer | 20-Jan-26 | Height | 173 cm | Weight | 71 kg | $450.00 | Squamous cell carcinoma | Treatment-naive | T3N2M1 | IV | G3 | Formation of the lower lobe of the right lung with metastases to the regional lymph nodes and pleura | Negative | |||
| BF19871487 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 52 Y | M | White | <-70C | 05-Jan-26 | Diagnosis | Lung cancer | 22-Dec-25 | Height | 176 cm | Weight | 74 kg | $1,800.00 | Squamous cell carcinoma | Treatment-naive | T4N2M1 | IV | G2 | Formation of the lower lobe of the left lung with metastases to the regional lymph nodes, pericardium and pleura | Negative | |||
| BF19871487-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 52 Y | M | White | <-70C | 05-Jan-26 | Diagnosis | Lung cancer | 22-Dec-25 | Height | 176 cm | Weight | 74 kg | $450.00 | Squamous cell carcinoma | Treatment-naive | T4N2M1 | IV | G2 | Formation of the lower lobe of the left lung with metastases to the regional lymph nodes, pericardium and pleura | Negative | |||
| BF19871488 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 67 Y | F | White | <-70C | 16-Feb-26 | Diagnosis | Lung cancer | 30-Jan-26 | Height | 169 cm | Weight | 74 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T2N2M1 | IV | G2 | Formation of the upper lobe of the left lung with metastases to the regional lymph nodes and pleura | Negative | |||
| BF19871488-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 67 Y | F | White | <-70C | 16-Feb-26 | Diagnosis | Lung cancer | 30-Jan-26 | Height | 169 cm | Weight | 74 kg | $450.00 | Adenocarcinoma | Treatment-naive | T2N2M1 | IV | G2 | Formation of the upper lobe of the left lung with metastases to the regional lymph nodes and pleura | Negative |